Furthermore, in luminal breast tumors, a notable overlap is observed between inactivating MAP3K1 or MAP2K4 mutations and activating mutations in the PIK3CA gene that codes the catalytic subunit (p110α) of phosphatidylinositol‐3‐kinase (PI3K; Ellis et al, 2012). Here, MAP2K4 is linked to breast neoplasm.